FindTrial
Sign In

Blood tests to predict severity of Covid

The role of NLR and other circulating biomarkers in predicting the prognosis of COVID-19

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/06/034190
Enrollment
200
Registered
2021-06-11
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

None listed

Sponsors

Dr Surag MK
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: RT-pcr positive Covid19 cases are included in the study

Exclusion criteria

Exclusion criteria: Covid positive patients with a primary diagnosis other than Covid pneumonia

Design outcomes

Primary

MeasureTime frame
deathTimepoint: 4 weeks—

Secondary

MeasureTime frame
Severe CovidTimepoint: 4 weeks—

Countries

India

Contacts

Public ContactDr Surag MK

Government Medical College,Kannur,Pariyaram

suragsreedhar@gmail.com9400480660

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026